Cytogenetic Response to Asciminib in Chronic Myeloid Leukemia With the e19a2 Micro BCR::ABL1 Transcript: A Case Report.
Terakawa T, Shingai Y, Matsuoka Y, Amemiya Y, Nakahara W, Tada Y, Yuda S, Fuji S, Ishikawa J, Yokota T.
Cureus. 2025 May 2;17(5):e83363. doi: 10.7759/cureus.83363. eCollection 2025 May.
Current status and future perspectives in targeted therapy of NPM1-mutated AML.
Ranieri R, Pianigiani G, Sciabolacci S, Perriello VM, Marra A, Cardinali V, Pierangeli S, Milano F, Gionfriddo I, Brunetti L, Martelli MP, Falini B.
Leukemia. 2022 Oct;36(10):2351-2367. doi: 10.1038/s41375-022-01666-2. Epub 2022 Aug 25.
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.
Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, Apperley JF, Szydlo R, Desai R, Kozlowski K, Paliompeis C, Latham V, Foroni L, Molimard M, Reid A, Rezvani K, de Lavallade H, Guallar C, Goldman J, Khorashad JS.
J Clin Oncol. 2010 May 10;28(14):2381-8. doi: 10.1200/JCO.2009.26.3087. Epub 2010 Apr 12.
Aberrant expression of human endogenous retrovirus K9-derived elements is associated with better clinical outcome of acute myelocytic leukemia.
Yanagiya R, Nakagawa S, Onizuka M, Kotani A.
Retrovirology. 2025 Apr 1;22(1):4. doi: 10.1186/s12977-025-00661-6.
Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.
Liersch R, Müller-Tidow C, Berdel WE, Krug U.
Br J Haematol. 2014 Apr;165(1):17-38. doi: 10.1111/bjh.12750. Epub 2014 Feb 1.
Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology.
Tomiyoshi K, Wilson LJ, Mourtada F, Mourtada JS, Namiki Y, Kamata W, Yang DJ, Inoue T.
Pharmaceutics. 2024 Nov 15;16(11):1458. doi: 10.3390/pharmaceutics16111458.
High incidence of minor and micro breakpoints in Chronic Myeloid Leukaemia with additional cytogenetic abnormalities at diagnosis - the Western Australian series.
Leung E, de Kraa R, Louw A, Cooney JP.
Leuk Res Rep. 2022 Aug 13;18:100344. doi: 10.1016/j.lrr.2022.100344. eCollection 2022.
Gut microbiome and metabolic response in non-alcoholic fatty liver disease.
Madatali Abuwani A, Priyadarshini Dash S, Ganesan R, Renu K, Vellingiri B, Kandasamy S, C R SR, Valsala Gopalakrishnan A.
Clin Chim Acta. 2021 Dec;523:304-314. doi: 10.1016/j.cca.2021.10.014. Epub 2021 Oct 16.
Testicular synovial sarcoma: a case report.
Nesrine M, Sellami R, Doghri R, Rifi H, Raies H, Mezlini A.
Cancer Biol Med. 2012 Dec;9(4):274-6. doi: 10.7497/j.issn.2095-3941.2012.04.010.
Genetic improvement of two Indian non-basmati aromatic rice landraces through physical and chemical mutagenesis.
Desai S, Jadhav A, Ramteke A, Dhole V, Bapat V, Gaikwad N.
Int J Radiat Biol. 2022;98(1):82-89. doi: 10.1080/09553002.2021.1987567. Epub 2021 Oct 18.
